American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

Teva Pharmaceutical Industries Limited

TEVA Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

TEVA historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of TEVA by members of U.S. Congress

Politician Type Traded
Alan Armstrong Senate / R Purchase $1,001 - $15,000 Mar 30, 2026
Greg Gianforte House / R Purchase $15,001 - $50,000 Nov 13, 2020
Donna E. Shalala House / D Sale $1,001 - $15,000 May 07, 2020
David E. Price House / D Sale $1,001 - $15,000 Jun 19, 2019
Thad Cochran Senate / R Purchase $15,001 - $50,000 Feb 12, 2018
Patty Murray Senate / D Sale (Full) $1,001 - $15,000 Jun 15, 2017
Thad Cochran Senate / R Sale (Full) $1,001 - $15,000 May 30, 2017
Thad Cochran Senate / R Purchase $1,001 - $15,000 Mar 17, 2017
Thad Cochran Senate / R Purchase $1,001 - $15,000 Mar 14, 2017
Cheri Bustos House / D Sale $1,001 - $15,000 Jan 30, 2017
Angus S. King Jr. Senate / I Sale (Full) $1,001 - $15,000 Oct 19, 2016
Thad Cochran Senate / R Sale (Full) $1,001 - $15,000 Sep 29, 2016
K. Michael Conaway House / R Sale $1,001 - $15,000 Sep 12, 2016
Thad Cochran Senate / R Purchase $15,001 - $50,000 Jun 01, 2016
K. Michael Conaway House / R Sale $1,001 - $15,000 May 11, 2016
K. Michael Conaway House / R Sale $1,001 - $15,000 May 04, 2016
Thad Cochran Senate / R Sale (Full) $1,001 - $15,000 Feb 02, 2016
Alan S. Lowenthal House / D Sale $15,001 - $50,000 Sep 11, 2015
Alan S. Lowenthal House / D Sale $15,001 - $50,000 Jul 27, 2015
K. Michael Conaway House / R Sale $1,001 - $15,000 Feb 09, 2015
Michael T. McCaul House / R Sale $15,001 - $50,000 Feb 01, 2015
Michael T. McCaul House / R Sale $15,001 - $50,000 Feb 01, 2015
Thomas MacArthur House / R Sale $1,001 - $15,000 Jan 27, 2015
Thomas MacArthur House / R Purchase $1,001 - $15,000 Jan 06, 2015
Alan S. Lowenthal House / D Purchase $15,001 - $50,000 Dec 19, 2014
Alan S. Lowenthal House / D Purchase $15,001 - $50,000 Dec 12, 2014
K. Michael Conaway House / R Sale $1,001 - $15,000 Mar 12, 2014
K. Michael Conaway House / R Purchase $1,001 - $15,000 Mar 06, 2014
TEVA Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
TEVA Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
TEVA Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in TEVA holdings by institutional investors

Insider Trading

Quarterly net insider trading by TEVA's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $2,050,000 Apr 20, 2022 Issue: Health Issues
  • $80,000 Apr 20, 2022 Issue: Health Issues
  • $60,000 Apr 20, 2022 Issue: Pharmacy Medicare/Medicaid Health Issues
  • $80,000 Apr 11, 2022 Issue: Pharmacy Health Issues
  • $60,000 Jan 24, 2022 Issue: Medicare/Medicaid Health Issues
  • $80,000 Jan 20, 2022 Issue: Health Issues
  • $600,000 Jan 20, 2022 Issue: HEALTH ISSUES
  • $80,000 Jan 13, 2022 Issue: Pharmacy Health Issues
  • $700,000 Oct 25, 2021 Issue: HEALTH ISSUES
  • $810,000 Oct 25, 2021 Issue: HEALTH ISSUES
  • $60,000 Oct 20, 2021 Issue: Medicare/Medicaid Health Issues
  • $80,000 Oct 18, 2021 Issue: Health Issues
  • $80,000 Oct 11, 2021 Issue: Pharmacy Health Issues
  • $80,000 Jul 19, 2021 Issue: Health Issues
  • $50,000 Jul 16, 2021 Issue: Medicare/Medicaid Health Issues
  • $80,000 Jul 12, 2021 Issue: Pharmacy Health Issues
  • $50,000 Apr 20, 2021 Issue: Health Issues
  • $50,000 Apr 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $1,820,000 Apr 20, 2021 Issue: HEALTH ISSUES
  • $30,000 Apr 12, 2021 Issue: None
  • $80,000 Apr 12, 2021 Issue: Pharmacy Health Issues
  • $50,000 Jan 21, 2021 Issue: Health Issues
  • $610,000 Jan 21, 2021 Issue: HEALTH ISSUES
  • $80,000 Jan 14, 2021 Issue: Pharmacy Health Issues
  • $80,000 Jan 13, 2021 Issue: Health Issues Pharmacy
  • $40,000 Oct 20, 2020 Issue: Health Issues
  • $500,000 Oct 19, 2020 Issue: HEALTH ISSUES
  • $80,000 Oct 15, 2020 Issue: Pharmacy Health Issues
  • $80,000 Oct 12, 2020 Issue: Health Issues Pharmacy
  • $580,000 Jul 16, 2020 Issue: None
  • $80,000 Jul 13, 2020 Issue: Pharmacy Health Issues
  • $30,000 Jul 07, 2020 Issue: Pharmacy Health Issues
  • $430,000 Apr 20, 2020 Issue: None
  • $80,000 Apr 14, 2020 Issue: Pharmacy Health Issues
  • $30,000 Apr 07, 2020 Issue: Pharmacy Health Issues
  • $410,000 Jan 21, 2020 Issue: None
  • $75,000 Jul 11, 2019 Issue: Pharmacy Health Issues
  • $30,000 Jul 05, 2019 Issue: Medicare/Medicaid Health Issues Pharmacy
  • $740,000 Jun 25, 2019 Issue: Health Issues Trade (domestic/foreign)
  • $30,000 Apr 09, 2019 Issue: Health Issues Medicare/Medicaid Pharmacy
  • $700,000 Jan 21, 2019 Issue: Health Issues
  • $1,130,000 Jul 20, 2018 Issue: Health Issues
  • $90,000 Apr 30, 2018 Issue: Pharmacy
  • $480,000 Apr 20, 2018 Issue: Health Issues
  • $20,000 Apr 20, 2018 Issue: Pharmacy Medicare/Medicaid Health Issues
  • $10,000 Apr 19, 2018 Issue: Health Issues Alcohol and Drug Abuse
  • $40,000 Mar 21, 2018 Issue: None
  • $50,000 Feb 08, 2018 Issue: Health Issues Medicare/Medicaid
  • $40,000 Jan 22, 2018 Issue: Health Issues Alcohol and Drug Abuse
  • $880,000 Jan 22, 2018 Issue: Health Issues Taxation/Internal Revenue Code
  • $90,000 Jan 21, 2018 Issue: Pharmacy
  • $60,000 Jan 18, 2018 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues Pharmacy
  • $50,000 Oct 27, 2017 Issue: Health Issues Medicare/Medicaid
  • $105,000 Oct 23, 2017 Issue: Pharmacy
  • $1,200,000 Oct 19, 2017 Issue: Health Issues Taxation/Internal Revenue Code
  • $60,000 Oct 19, 2017 Issue: Pharmacy Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $40,000 Oct 19, 2017 Issue: Alcohol and Drug Abuse Health Issues
  • $50,000 Aug 08, 2017 Issue: Health Issues Medicare/Medicaid
  • $60,000 Jul 20, 2017 Issue: Pharmacy Health Issues Taxation/Internal Revenue Code Government Issues Medicare/Medicaid
  • $840,000 Jul 20, 2017 Issue: Health Issues Taxation/Internal Revenue Code
  • $40,000 Jul 19, 2017 Issue: Alcohol and Drug Abuse Health Issues
  • $50,000 May 08, 2017 Issue: Medicare/Medicaid Health Issues
  • $40,000 Apr 20, 2017 Issue: Health Issues Taxation/Internal Revenue Code
  • $2,670,000 Apr 20, 2017 Issue: Health Issues Taxation/Internal Revenue Code
  • $105,000 Apr 20, 2017 Issue: Pharmacy
  • $50,000 Apr 19, 2017 Issue: Alcohol and Drug Abuse Health Issues
  • $1,170,000 Jan 31, 2017 Issue: Pharmacy Trade (domestic/foreign) Copyright/Patent/Trademark
  • $30,000 Jan 27, 2017 Issue: Pharmacy
  • $60,000 Jan 19, 2017 Issue: Health Issues Alcohol and Drug Abuse
  • $50,000 Jan 18, 2017 Issue: Medicare/Medicaid Health Issues
  • $105,000 Jan 17, 2017 Issue: Pharmacy
  • $30,000 Feb 09, 2016 Issue: Pharmacy
  • $50,000 Feb 03, 2016 Issue: Health Issues
  • $45,000 Jan 28, 2016 Issue: Pharmacy
  • $45,000 Jan 28, 2016 Issue: Pharmacy
  • $105,000 Jan 20, 2016 Issue: Pharmacy
  • $60,000 Jan 20, 2016 Issue: Health Issues Labor Issues/Antitrust/Workplace Alcohol and Drug Abuse
  • $900,000 Jan 20, 2016 Issue: Trade (domestic/foreign) Copyright/Patent/Trademark Pharmacy
  • $105,000 Oct 21, 2015 Issue: Pharmacy
  • $60,000 Oct 20, 2015 Issue: Labor Issues/Antitrust/Workplace Alcohol and Drug Abuse Health Issues
  • $50,000 Oct 20, 2015 Issue: Health Issues
  • $990,000 Oct 19, 2015 Issue: Pharmacy Trade (domestic/foreign) Copyright/Patent/Trademark
  • $45,000 Jul 23, 2015 Issue: Pharmacy
  • $60,000 Jul 20, 2015 Issue: Alcohol and Drug Abuse Health Issues
  • $980,000 Jul 16, 2015 Issue: Pharmacy Trade (domestic/foreign)
  • $105,000 Jul 16, 2015 Issue: Pharmacy
  • $50,000 Jul 16, 2015 Issue: Health Issues
  • $10,000 Jul 13, 2015 Issue: Pharmacy
  • $45,000 Apr 27, 2015 Issue: Pharmacy
  • $50,000 Apr 20, 2015 Issue: Health Issues
  • $60,000 Apr 20, 2015 Issue: Alcohol and Drug Abuse Health Issues
  • $105,000 Apr 20, 2015 Issue: Pharmacy
  • $1,200,000 Apr 19, 2015 Issue: Trade (domestic/foreign) Pharmacy
  • $890,000 Jan 20, 2015 Issue: Pharmacy Trade (domestic/foreign)
  • $880,000 Oct 20, 2014 Issue: Pharmacy Trade (domestic/foreign)
  • $870,000 Jul 21, 2014 Issue: Pharmacy Trade (domestic/foreign) Copyright/Patent/Trademark
  • $1,160,000 Apr 18, 2014 Issue: Pharmacy Copyright/Patent/Trademark Trade (domestic/foreign)
  • $800,000 Jan 17, 2014 Issue: Pharmacy Copyright/Patent/Trademark Trade (domestic/foreign)
  • $810,000 Oct 21, 2013 Issue: Pharmacy Copyright/Patent/Trademark Tariff (miscellaneous tariff bills) Trade (domestic/foreign)
  • $820,000 Jul 22, 2013 Issue: Tariff (miscellaneous tariff bills) Pharmacy Copyright/Patent/Trademark Trade (domestic/foreign)
Revolving Door

Former government officials who have lobbied for TEVA

2 former government officials from 2 congressional offices at 1 lobbying firm have lobbied for TEVA, most recently Jan 21, 2020.

  • Lee Terry
    Michael Brzica House New Legislative Counsel, Rep. Lee Terry (2007-2009) Formerly with Lee Terry · TEVA PHARMACEUTICALS USA, INC. · Jan 21, 2020
  • Christopher J. Dodd
    James Fenton Senate New Chief of Staff, Leg. Director, & Staff Assist. to Sen. Chris Dodd, and Prof. Staff Member of Senate HELP Subcommittee on Children & Families, Chaired by Sen. Dodd (1996-2011) Formerly with Christopher J. Dodd · TEVA PHARMACEUTICALS USA, INC. · Jan 22, 2018
Corporate Lobbying

TEVA Estimated quarterly lobbying spending

Revenue Breakdown

TEVA Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
TEVA Income Statement
TEVA Balance Sheet
TEVA Cash Flow
U.S. Patents

New TEVA patent grants

  • Patent Title: Injector pen Nov. 23, 2021
  • Patent Title: Injector pen Aug. 28, 2018
  • Patent Title: S1p3 antagonists Apr. 24, 2018
  • Patent Title: Re-useable injector device for syringe Nov. 28, 2017
  • Patent Title: Process for manufacturing glatiramer acetate product Sep. 19, 2017
  • Patent Title: Process for manufacturing glatiramer acetate product Jul. 18, 2017
  • Patent Title: Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis Jun. 27, 2017
  • Patent Title: Laquinimod for the treatment of relapsing-remitting multiple sclerosis (rrms) patients with a high disability status May. 30, 2017
  • Patent Title: Dose counter and recording method Apr. 18, 2017
  • Patent Title: Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate Apr. 18, 2017
  • Patent Title: Respiratory apparatus Apr. 11, 2017
  • Patent Title: Respiratory apparatus Apr. 11, 2017
  • Patent Title: Respiratory apparatus Apr. 11, 2017
  • Patent Title: Respiratory apparatus Apr. 11, 2017
  • Patent Title: Biomarkers predictive for clinical response for glatiramer acetate Apr. 11, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Apr. 04, 2017
  • Patent Title: Respiratory appartus Apr. 04, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Respiratory apparatus Mar. 28, 2017
  • Patent Title: Treatment of bdnf-related disorders using laquinimod Mar. 07, 2017
  • Patent Title: Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate Nov. 22, 2016
  • Patent Title: Formulations of albu-bche, preparation and uses thereof Aug. 09, 2016
  • Patent Title: Formulations of 6-mercaptopurine Jun. 28, 2016
  • Patent Title: R(+)-n-formyl-propargyl-aminoindan May. 24, 2016
  • Patent Title: Stable laquinimod preparations May. 17, 2016
  • Patent Title: R(+)-n-methyl-propargyl-aminoindan May. 17, 2016
  • Patent Title: Injector device for a syringe Dec. 15, 2015
  • Patent Title: Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids Nov. 05, 2013
  • Patent Title: Inhaler May. 29, 2012
  • Patent Title: Inhaler May. 22, 2012
  • Patent Title: Inhaler May. 22, 2012
  • Patent Title: Package for medicines May. 15, 2012
  • Patent Title: Auto injection device Mar. 15, 2011
  • Patent Title: Auto injection device with over mould grip Mar. 15, 2011
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to TEVA from public contracts

TEVA News

Recent insights relating to TEVA

CNBC Recommendations

Recent picks made for TEVA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in TEVA

TEVA Analyst Ratings

TEVA Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
TEVA Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $TEVA stock a Buy, Sell, or Hold?

  • What is the price target for $TEVA stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

TEVA Top Shareholders
Shareholder
Shares Held
TEVA Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $TEVA stock?

  • Who owns the most shares of $TEVA stock?

  • What funds own $TEVA stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

TEVA Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view TEVA Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About TEVA

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Teva Pharmaceutical Industries Limited (TEVA) Historical Stock Prices

Teva Pharmaceutical Industries Limited (TEVA) closed at $39.01 on September 23, 2026. Over the past year its adjusted close ranged from $18.34 to $40.06. Daily prices go back to January 2, 2014, 3,200 trading days in all.

  • 1 month+5.63%
  • 3 months+14.00%
  • Year to date+24.99%
  • 1 year+100.57%
  • 3 years+276.91%
  • 5 years+335.87%
  • Max+6.94%
See every congressional and insider trade on the TEVA price chart

Quiver Premium charts TEVA's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 39.68 40.09 38.92 39.01 39.01 6,138,747
Sep 22, 2026 39.45 40.14 39.05 39.52 39.52 4,542,856
Sep 21, 2026 39.09 40.79 38.36 40.06 40.06 5,941,719
Sep 18, 2026 38.90 39.38 38.66 38.98 38.98 5,477,350
Sep 17, 2026 38.96 39.70 38.71 39.19 39.19 5,521,445
Sep 16, 2026 39.02 39.52 38.32 38.53 38.53 4,821,843
Sep 15, 2026 38.71 39.49 38.11 39.25 39.25 7,127,917
Sep 14, 2026 37.66 39.22 37.00 38.72 38.72 4,381,992
Sep 11, 2026 36.46 37.11 36.06 37.09 37.09 2,855,422
Sep 10, 2026 36.37 36.75 36.04 36.35 36.35 4,014,361
Sep 9, 2026 36.82 37.31 36.47 36.85 36.85 3,999,774
Sep 8, 2026 35.89 36.97 35.42 36.76 36.76 4,623,970
Sep 4, 2026 36.40 36.93 36.13 36.36 36.36 7,402,523
Sep 3, 2026 37.98 38.06 36.33 36.62 36.62 3,904,536
Sep 2, 2026 36.65 37.59 35.74 37.49 37.49 7,690,282
Sep 1, 2026 36.52 36.55 35.85 36.19 36.19 3,515,716
Aug 31, 2026 36.17 36.33 35.62 36.05 36.05 5,778,765
Aug 28, 2026 37.37 37.42 36.37 36.44 36.44 3,140,917
Aug 27, 2026 37.72 38.37 37.53 37.62 37.62 4,721,594
Aug 26, 2026 37.70 38.05 37.07 37.92 37.92 4,816,066
Aug 25, 2026 37.13 38.11 37.09 38.10 38.10 5,279,134
Aug 24, 2026 37.30 37.32 36.75 36.93 36.93 3,338,943
Aug 21, 2026 36.79 37.75 36.65 37.34 37.34 4,300,154
Aug 20, 2026 37.12 37.34 36.73 36.81 36.81 4,513,451
Aug 19, 2026 37.00 37.83 36.60 37.47 37.47 7,975,798
Aug 18, 2026 36.47 37.25 36.34 36.58 36.58 6,197,596
Aug 17, 2026 36.53 36.78 35.99 36.46 36.46 3,584,896
Aug 14, 2026 36.26 36.81 36.09 36.77 36.77 2,332,543
Aug 13, 2026 36.90 37.39 36.46 36.52 36.52 7,608,870
Aug 12, 2026 36.80 37.24 36.44 36.74 36.74 5,700,975
Aug 11, 2026 36.17 36.98 36.13 36.48 36.48 8,040,857
Aug 10, 2026 35.03 36.14 35.00 36.14 36.14 5,608,050
Aug 7, 2026 35.00 35.77 34.87 35.36 35.36 4,271,884
Aug 6, 2026 34.54 34.92 34.38 34.81 34.81 4,132,286
Aug 5, 2026 34.25 34.98 33.89 34.72 34.72 4,963,166
Aug 4, 2026 34.62 34.65 34.05 34.43 34.43 4,924,515
Aug 3, 2026 35.00 35.07 33.78 34.46 34.46 6,208,661
Jul 31, 2026 35.60 35.66 34.56 35.01 35.01 4,695,343
Jul 30, 2026 34.35 35.87 34.27 35.41 35.41 8,768,529
Jul 29, 2026 33.67 35.69 33.48 34.71 34.71 17,760,927
Jul 28, 2026 31.18 31.88 31.02 31.67 31.67 5,056,277
Jul 27, 2026 31.27 31.29 30.91 31.08 31.08 5,305,668
Jul 24, 2026 31.23 31.86 30.77 30.81 30.81 3,132,683
Jul 23, 2026 29.94 31.20 29.60 31.18 31.18 4,451,647
Jul 22, 2026 30.86 31.20 30.13 30.15 30.15 5,116,994
Jul 21, 2026 31.13 31.53 30.72 31.35 31.35 4,849,308
Jul 20, 2026 32.24 32.26 30.95 31.00 31.00 4,515,318
Jul 17, 2026 32.13 32.69 31.95 32.03 32.03 3,612,359
Jul 16, 2026 31.64 32.42 31.54 32.22 32.22 4,453,698
Jul 15, 2026 31.82 31.97 31.28 31.56 31.56 5,519,683
Jul 14, 2026 32.04 32.27 31.66 31.82 31.82 3,452,186
Jul 13, 2026 32.52 32.81 32.14 32.18 32.18 4,231,527
Jul 10, 2026 33.02 33.35 32.70 32.95 32.95 6,638,420
Jul 9, 2026 32.89 33.14 32.41 33.10 33.10 5,112,938
Jul 8, 2026 34.17 34.17 32.57 33.24 33.24 6,623,728
Jul 7, 2026 35.21 35.33 34.23 34.65 34.65 5,566,054
Jul 6, 2026 35.00 35.47 34.58 35.29 35.29 4,116,819
Jul 2, 2026 33.87 34.92 33.59 34.64 34.64 4,815,447
Jul 1, 2026 33.83 34.08 33.26 33.44 33.44 4,241,435
Jun 30, 2026 33.28 34.28 33.00 33.88 33.88 5,396,075
Jun 29, 2026 33.10 33.48 32.96 33.31 33.31 3,271,624
Jun 26, 2026 33.47 34.14 32.96 33.21 33.21 4,703,604
Jun 25, 2026 34.14 34.69 33.40 33.62 33.62 7,448,003
Jun 24, 2026 33.32 34.59 33.16 34.22 34.22 7,249,291
Jun 23, 2026 32.14 33.34 32.12 33.21 33.21 5,567,372
Jun 22, 2026 31.37 32.39 31.28 32.20 32.20 6,111,093
Jun 18, 2026 32.38 32.38 30.80 31.48 31.48 12,241,543
Jun 17, 2026 32.74 32.92 32.23 32.56 32.56 5,539,753
Jun 16, 2026 33.58 33.70 32.80 32.91 32.91 5,304,899
Jun 15, 2026 34.91 35.25 33.62 33.69 33.69 5,241,832
Jun 12, 2026 34.81 34.88 33.88 34.63 34.63 5,928,086
Jun 11, 2026 34.01 34.74 33.98 34.56 34.56 7,228,710
Jun 10, 2026 34.02 34.20 33.48 33.58 33.58 3,857,844
Jun 9, 2026 33.48 34.48 32.91 34.45 34.45 6,366,856
Jun 8, 2026 34.35 34.95 33.07 33.26 33.26 5,750,586
Jun 5, 2026 34.30 35.01 34.09 34.19 34.19 5,713,369
Jun 4, 2026 33.07 34.48 33.00 34.43 34.43 5,575,695
Jun 3, 2026 32.83 32.98 32.37 32.83 32.83 5,070,028
Jun 2, 2026 34.15 34.15 32.51 33.08 33.08 10,282,222
Jun 1, 2026 34.64 34.77 33.84 34.64 34.64 6,626,153
May 29, 2026 34.79 35.47 34.52 35.32 35.32 16,852,842
May 28, 2026 34.18 34.84 33.69 34.52 34.52 3,497,389
May 27, 2026 34.65 35.15 34.40 34.56 34.56 4,357,493
May 26, 2026 34.54 34.93 34.16 34.61 34.61 4,445,477
May 22, 2026 34.29 34.85 34.02 34.07 34.07 2,710,347
May 21, 2026 34.10 34.37 33.75 34.16 34.16 4,605,560
May 20, 2026 34.24 34.55 34.08 34.32 34.32 6,312,445
May 19, 2026 34.00 34.23 33.69 34.07 34.07 3,060,095
May 18, 2026 34.15 34.98 33.84 34.03 34.03 4,976,941
May 15, 2026 34.79 34.88 33.61 34.29 34.29 6,694,884
May 14, 2026 36.01 36.08 35.06 35.31 35.31 5,522,628
May 13, 2026 35.80 36.38 35.42 36.25 36.25 4,458,384
May 12, 2026 35.37 35.84 34.91 35.81 35.81 4,625,487
May 11, 2026 35.71 36.43 35.68 35.84 35.84 5,872,125
May 8, 2026 36.26 36.33 35.43 35.73 35.73 8,220,835
May 7, 2026 36.42 36.99 35.59 36.01 36.01 10,802,320
May 6, 2026 36.37 36.52 35.62 36.34 36.34 6,915,075
May 5, 2026 35.52 35.97 35.08 35.86 35.86 6,250,081
May 4, 2026 35.04 35.98 35.02 35.35 35.35 7,514,271
May 1, 2026 35.16 35.18 34.51 34.95 34.95 6,629,922
Apr 30, 2026 36.02 36.02 34.63 35.07 35.07 16,090,261
Apr 29, 2026 34.00 35.62 33.92 35.38 35.38 22,287,058
Apr 28, 2026 31.19 31.84 31.09 31.62 31.62 9,307,320
Apr 27, 2026 30.65 31.66 30.58 31.26 31.26 8,072,965
Apr 24, 2026 31.26 31.45 30.02 30.64 30.64 4,826,802
Apr 23, 2026 30.95 31.27 30.64 31.21 31.21 3,606,169
Apr 22, 2026 31.50 31.68 30.89 31.22 31.22 3,511,630
Apr 21, 2026 32.04 32.04 31.24 31.29 31.29 3,728,475
Apr 20, 2026 32.27 32.44 32.01 32.02 32.02 4,963,535
Apr 17, 2026 31.30 32.81 31.27 32.40 32.40 4,512,288
Apr 16, 2026 31.72 31.75 31.20 31.26 31.26 4,682,232
Apr 15, 2026 31.49 31.67 31.10 31.61 31.61 3,318,608
Apr 14, 2026 31.30 31.95 31.29 31.77 31.77 4,292,401
Apr 13, 2026 30.66 31.20 30.41 31.15 31.15 3,056,236
Apr 10, 2026 31.26 31.39 30.58 30.82 30.82 4,276,659
Apr 9, 2026 30.45 31.00 30.22 30.96 30.96 3,425,055
Apr 8, 2026 30.11 30.75 29.97 30.52 30.52 6,122,402
Apr 7, 2026 29.25 29.58 28.94 29.33 29.33 5,703,266
Apr 6, 2026 29.09 30.00 27.93 29.82 29.82 4,294,271
Apr 2, 2026 29.45 30.35 29.40 30.08 30.08 2,843,879
Apr 1, 2026 30.48 30.71 30.10 30.25 30.25 4,578,901
Mar 31, 2026 28.77 30.14 28.71 30.12 30.12 6,556,708
Mar 30, 2026 28.86 29.04 28.29 28.35 28.35 4,984,851
Mar 27, 2026 29.40 29.52 28.62 28.74 28.74 5,572,794
Mar 26, 2026 29.04 29.84 29.01 29.78 29.78 7,065,098
Mar 25, 2026 29.35 30.42 29.28 29.46 29.46 8,170,957
Mar 24, 2026 28.51 29.25 28.30 29.14 29.14 8,218,681
Mar 23, 2026 28.94 29.39 28.65 28.77 28.77 5,134,978
Mar 20, 2026 29.64 29.75 28.50 28.73 28.73 6,292,907
Mar 19, 2026 29.25 29.77 28.89 29.44 29.44 8,758,950
Mar 18, 2026 29.94 30.24 29.54 29.61 29.61 6,112,331
Mar 17, 2026 29.63 30.30 29.49 30.09 30.09 9,528,777
Mar 16, 2026 28.99 29.73 28.85 29.46 29.46 8,366,994
Mar 13, 2026 29.38 29.68 28.38 28.57 28.57 7,773,810
Mar 12, 2026 29.97 30.23 29.27 29.30 29.30 7,411,004
Mar 11, 2026 31.38 31.43 30.36 30.47 30.47 10,520,707
Mar 10, 2026 31.38 31.91 31.26 31.52 31.52 8,295,388
Mar 9, 2026 30.53 31.51 29.92 31.50 31.50 11,115,901
Mar 6, 2026 31.15 31.40 30.74 31.05 31.05 7,786,903
Mar 5, 2026 32.34 32.35 31.24 31.75 31.75 9,928,459
Mar 4, 2026 33.18 33.30 32.02 32.91 32.91 9,422,575
Mar 3, 2026 32.83 32.88 31.71 32.28 32.28 10,379,445
Mar 2, 2026 33.85 34.20 33.56 33.77 33.77 6,008,022
Feb 27, 2026 33.50 33.88 33.04 33.86 33.86 9,034,733
Feb 26, 2026 33.57 33.90 33.31 33.77 33.77 5,429,578
Feb 25, 2026 34.00 34.13 33.60 33.62 33.62 3,537,061
Feb 24, 2026 33.69 34.22 33.52 33.92 33.92 2,966,252
Feb 23, 2026 33.96 34.92 33.62 33.91 33.91 4,778,167
Feb 20, 2026 34.40 35.18 33.14 34.22 34.22 8,209,939
Feb 19, 2026 33.80 34.43 33.50 34.33 34.33 6,875,486
Feb 18, 2026 34.20 34.40 33.57 34.11 34.11 7,247,073
Feb 17, 2026 35.25 35.32 34.02 34.41 34.41 10,037,732
Feb 13, 2026 33.92 34.25 33.70 33.98 33.98 5,010,709
Feb 12, 2026 34.35 34.35 33.72 33.92 33.92 6,025,549
Feb 11, 2026 34.80 34.80 33.92 34.31 34.31 5,458,017
Feb 10, 2026 34.59 34.73 34.20 34.37 34.37 6,141,841
Feb 9, 2026 34.57 34.63 34.27 34.47 34.47 7,552,398
Feb 6, 2026 35.00 35.11 34.61 34.69 34.69 7,035,995
Feb 5, 2026 34.90 35.26 34.20 34.80 34.80 10,555,844
Feb 4, 2026 36.18 36.59 34.88 34.96 34.96 11,937,640
Feb 3, 2026 35.53 37.34 35.53 36.25 36.25 22,299,868
Feb 2, 2026 34.45 35.69 34.15 35.52 35.52 19,029,080
Jan 30, 2026 32.49 34.11 32.35 34.08 34.08 16,970,949
Jan 29, 2026 33.26 33.44 32.19 33.07 33.07 10,524,264
Jan 28, 2026 31.39 33.38 30.94 33.21 33.21 21,862,554
Jan 27, 2026 32.22 32.56 31.57 32.53 32.53 14,199,072
Jan 26, 2026 31.90 32.20 31.62 32.14 32.14 12,165,113
Jan 23, 2026 31.62 32.03 31.50 31.81 31.81 5,400,862
Jan 22, 2026 31.54 31.85 31.42 31.66 31.66 6,459,690
Jan 21, 2026 31.45 31.79 31.21 31.41 31.41 6,783,158
Jan 20, 2026 30.77 31.94 30.70 31.36 31.36 7,358,487
Jan 16, 2026 32.33 32.37 31.58 31.76 31.76 7,220,039
Jan 15, 2026 32.25 32.76 32.00 32.35 32.35 9,002,196
Jan 14, 2026 31.95 32.85 31.92 32.64 32.64 9,884,399
Jan 13, 2026 32.66 32.81 31.98 32.47 32.47 7,245,036
Jan 12, 2026 33.23 33.42 32.60 32.79 32.79 15,096,192
Jan 9, 2026 32.49 32.73 31.80 32.01 32.01 9,573,581
Jan 8, 2026 32.38 32.87 32.20 32.51 32.51 11,668,806
Jan 7, 2026 32.87 32.87 32.26 32.40 32.40 9,034,520
Jan 6, 2026 31.63 32.91 31.56 32.11 32.11 19,010,690
Jan 5, 2026 30.98 31.09 30.49 31.00 31.00 15,909,206
Jan 2, 2026 31.18 31.44 30.47 30.95 30.95 7,137,697
Dec 31, 2025 31.42 31.43 31.15 31.21 31.21 4,941,890
Dec 30, 2025 31.50 31.62 31.31 31.34 31.34 3,785,330
Dec 29, 2025 31.50 31.73 31.17 31.56 31.56 4,618,797
Dec 26, 2025 31.53 31.89 31.47 31.89 31.89 2,624,737
Dec 24, 2025 31.99 31.99 31.50 31.74 31.74 3,794,297
Dec 23, 2025 31.38 31.58 31.18 31.54 31.54 15,427,779
Dec 22, 2025 30.72 31.28 30.50 31.21 31.21 8,764,401
Dec 19, 2025 30.10 30.56 29.89 30.35 30.35 10,758,752
Dec 18, 2025 30.29 30.39 29.88 30.32 30.32 8,058,299
Dec 17, 2025 30.11 30.24 29.88 30.06 30.06 7,230,101
Dec 16, 2025 30.12 30.42 29.84 30.10 30.10 6,633,153
Dec 15, 2025 29.78 30.44 29.70 30.13 30.13 12,982,013
Dec 12, 2025 30.00 30.13 29.55 29.79 29.79 9,317,652
Dec 11, 2025 29.59 30.20 29.47 30.18 30.18 9,879,928
Dec 10, 2025 29.16 29.80 28.81 29.80 29.80 17,807,783
Dec 9, 2025 29.07 29.10 28.52 28.56 28.56 11,801,277
Dec 8, 2025 28.74 28.74 28.00 28.33 28.33 7,178,300
Dec 5, 2025 28.40 28.68 28.00 28.46 28.46 8,529,559
Dec 4, 2025 28.00 28.46 27.95 28.41 28.41 11,021,506
Dec 3, 2025 26.93 27.90 26.84 27.83 27.83 13,650,982
Dec 2, 2025 26.99 27.07 26.52 26.88 26.88 8,942,430
Dec 1, 2025 26.60 26.77 26.46 26.72 26.72 8,887,120
Nov 28, 2025 26.47 26.96 26.39 26.89 26.89 9,046,532
Nov 26, 2025 25.90 26.45 25.74 26.32 26.32 18,354,961
Nov 25, 2025 24.97 25.18 24.78 24.99 24.99 7,207,357
Nov 24, 2025 24.50 24.90 24.34 24.77 24.77 11,082,110
Nov 21, 2025 24.33 24.80 24.01 24.21 24.21 9,829,167
Nov 20, 2025 24.59 24.89 24.21 24.28 24.28 6,317,808
Nov 19, 2025 24.97 24.97 24.16 24.44 24.44 9,670,462
Nov 18, 2025 24.43 25.07 24.21 24.84 24.84 11,692,654
Nov 17, 2025 25.26 25.50 24.48 24.59 24.59 11,996,319
Nov 14, 2025 24.95 25.67 24.90 25.41 25.41 10,222,311
Nov 13, 2025 26.00 26.38 25.50 25.54 25.54 16,192,322
Nov 12, 2025 25.21 25.88 25.18 25.83 25.83 15,647,554
Nov 11, 2025 24.38 25.35 24.28 25.13 25.13 15,259,902
Nov 10, 2025 24.07 24.50 23.98 24.26 24.26 11,580,803
Nov 7, 2025 24.38 24.42 23.61 23.97 23.97 13,107,628
Nov 6, 2025 24.05 24.88 23.87 24.46 24.46 24,231,364
Nov 5, 2025 23.06 25.00 22.70 24.60 24.60 56,470,122
Nov 4, 2025 20.26 20.72 20.11 20.46 20.46 10,956,651
Nov 3, 2025 20.60 20.88 20.30 20.52 20.52 10,630,108
Oct 31, 2025 20.17 20.60 19.98 20.48 20.48 9,384,389
Oct 30, 2025 20.12 20.38 20.00 20.03 20.03 6,198,342
Oct 29, 2025 19.97 20.62 19.89 20.23 20.23 17,115,520
Oct 28, 2025 19.68 19.98 19.23 19.78 19.78 9,490,659
Oct 27, 2025 19.15 19.68 19.00 19.61 19.61 8,653,535
Oct 24, 2025 19.07 19.19 18.88 18.95 18.95 5,211,430
Oct 23, 2025 19.07 19.18 18.84 19.02 19.02 5,700,685
Oct 22, 2025 18.98 19.19 18.82 18.97 18.97 11,060,155
Oct 21, 2025 19.27 19.30 18.97 18.99 18.99 8,037,148
Oct 20, 2025 19.29 19.45 19.07 19.42 19.42 5,324,782
Oct 17, 2025 19.40 19.69 19.07 19.31 19.31 7,731,290
Oct 16, 2025 19.86 20.10 19.61 19.63 19.63 10,048,908
Oct 15, 2025 19.96 20.02 19.72 19.78 19.78 8,627,295
Oct 14, 2025 19.85 20.27 19.68 20.11 20.11 6,550,555
Oct 13, 2025 20.11 20.37 19.80 20.02 20.02 7,509,734
Oct 10, 2025 20.00 20.05 19.77 20.03 20.03 8,204,439
Oct 9, 2025 20.65 20.71 19.71 20.04 20.04 9,878,169
Oct 8, 2025 20.25 20.57 20.09 20.21 20.21 13,132,973
Oct 7, 2025 19.95 20.28 19.91 20.07 20.07 5,017,897
Oct 6, 2025 20.02 20.23 19.87 19.96 19.96 9,328,201
Oct 3, 2025 20.17 20.61 19.98 20.01 20.01 10,344,183
Oct 2, 2025 20.02 20.10 19.81 20.05 20.05 6,508,883
Oct 1, 2025 20.15 20.46 19.91 20.06 20.06 13,339,804
Sep 30, 2025 19.39 20.43 19.26 20.20 20.20 19,946,530
Sep 29, 2025 18.49 19.18 18.47 19.18 19.18 8,500,848
Sep 26, 2025 18.50 18.70 18.27 18.34 18.34 10,255,399
Sep 25, 2025 19.09 19.10 18.21 18.36 18.36 10,371,526
Sep 24, 2025 19.45 19.45 19.16 19.27 19.27 9,134,327
Sep 23, 2025 18.92 19.89 18.80 19.45 19.45 12,890,395

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Teva Pharmaceutical Industries Limited Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at TEVA, per a recent SEC DEF 14A filing. We estimate that the median employee at TEVA PHARMACEUTICAL INDUSTRIES LTD is paid $66,199.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation